Cantargia today presented new preclinical data for its lead candidate, the IL1RAP-binding antibody nadunolimab at the AACR Annual Meeting. The data show that nadunolimab targets a fundamental...
Related Keywords
California , United States , San Diego , Nicholas Willumsen , Lund University , Nordic Bioscience ,
comparemela.com © 2020. All Rights Reserved.